M G Castro

Molecular indetermination in the transition to error catastrophe: Systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity

E. Domingo, P. Lowenstein, A. Grande-Pérez, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Studies on the prolactin-releasing mechanism of histones H2A and H2B.

M. Castro, M G Castro, O A Brown, 2000, Life sciences.

Regulatable gene expression systems for gene therapy applications: progress and future challenges.

C. Barcia, P. Lowenstein, James F Curtin, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Current and future strategies for the treatment of malignant brain tumors.

Xiangpeng Yuan, J. Williams, P. Lowenstein, 2003, Pharmacology & therapeutics.

Viral vectors for gene delivery and gene therapy within the endocrine system.

P. Lowenstein, M. Castro, A. David, 2000, The Journal of endocrinology.

Strong promoters are the key to highly efficient, noninflammatory and noncytotoxic adenoviral-mediated transgene delivery into the brain in vivo.

P. Lowenstein, M. Castro, M G Castro, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.